EU, FDA to share inspections data; EU signs off on Optimer, Astellas, diarrhea drug DIFICLIR;

  @FiercePharma: NHS data on prescriptions to be opened up to public under open data initiative. Story | Follow@FiercePharma

> Starting in January 2012, the European Medicines Agency and the U.S. FDA will begin to share their inspections data of manufacturing sites in each other's territories. Story

> Optimer Pharmaceuticals ($OPTR) and Astellas Pharma have gained marketing approval in Europe for DIFICLIR (fidaxomicin) tablets to treat adults with Clostridium difficile-associated diarrhea. Optimer release

> Takeda will begin Canadian marketing of AMAG Pharmaceuticals' ($AMAG) Feraheme, a new intravenous treatment for iron deficiency anemia in patients with chronic kidney disease, following the drug's Dec. 8 regulatory approval. Release

> Mylan ($MYL) has appointed John Thievon, former president and CEO of MiddleBrook Pharmaceuticals, as president of Dey Pharma, the company's fully integrated specialty pharmaceutical business. Mylan release

>The board of directors at Eli Lilly ($LLY) have elected Katherine Baicker as a new member. The health economics professor at the Harvard School of Public Health will serve on Lilly's public policy and compliance committee. Lilly release

Biotech News 

@FierceBiotech: Interesting piece from @eyeonfda on social media guidelines and clinical trials. Article | Follow @FierceBiotech

@JohnCFierce: Abbott bets $400M on Reata preclinical-in which CEO Huff laughs, tells me "no comment" on Abbott buyout bid. | Follow @JohnCFierce

@RyanMFierce: Say lots about FDA, but France's drug regulatory system looks like a mess in comparison. Article on Mediator scandal. | Follow @RyanMFierce

@MaureenFierce: Writing for New Scientist, the CEO of the UK's Science Media Center proposes 5 ways to fix science journalism. Article | Follow @MaureenFierce

> Gene therapy study offers proof of potential breakthrough on hemophilia. Item

> Pharmacyclics impresses (again) with improved leukemia data on blockbuster hopeful. Report

> Onyx shares slide after FDA forces investors to wait on standard carfilzomib review. News

Biotech IT News

> Pharma hacker gets jail sentence in NJ. Story

> Supercomputer software aids UK cancer researchers. Report

> IBM taps 'Watson-type' tech for drug research tool. Item

> Uncle Sam to award $20M for work on genomic data informatics. Report

> U. Cal professor recruits computer whizzes for war on cancer. Article

> U.K. injecting £75M into bioinformatics 'nerve center' for Europe. News

Medical Device News

> Bluegrass announces patient enrollment in catheter trial. News

> Boston Sci introduces Charger catheter. Report

> Tissue Regenix to raise $39M, eyes job creation. Article

> Symmetry to buy instruments biz of J&J unit for $165M. Story

And Finally... Bayer, the maker of Yaz, wants the Pennsylvania Supreme Court to take action against Philadelphia's common pleas court, which it says is actively encouraging out-of-state lawsuits over the drug. News